phs000592.v1.p1 Screening Protocol and Longitudinal Study of Bone Marrow Failure Syndromes and Cytopenias | Version 1: passed embargo
| VDAS | 341 | Longitudinal, Prospective | Links | |
phs001516.v1.p1 Phenotype Risk Score Study of Rare Variants | Version 1: passed embargo
| VDAS | 21701 | Cohort | Links | Infinium HumanExome BeadChip
|
phs001419.v1.p1 INC Natural History Study | Version 1: passed embargo
| VDAS | 1002 | Longitudinal | Links | |
phs000228.v4.p1 HMP Core Microbiome Sampling Protocol A (HMP-A) | Versions 1-4: passed embargo
| VDAS | 300 | Population-Based Control Set | Links | 454 GS FLX Titanium 454 GS FLX Titanium
|
phs000353.v1.p1 GENEVA Study of Preterm Delivery (African-American) | Version 1: passed embargo
| VDAS | 3478 | Case-Control | Links | HumanOmni1-Quad_v1-0_B
|
phs001584.v1.p1 eMERGE Network Phase III: HRC Imputed Array Data of 83,000+ Participants | Version 1: passed embargo
| VDAS | 83717 | Case-Control | | Nimblegen Custom SeqCap
|
phs000888.v1.p1 eMERGE Network Imputed GWAS for 41 phenotypes | Version 1: passed embargo
| VDAS | 55029 | Case-Control, Cohort | Links | 1000 Genomes
|
phs000345.v1.p1 NIDDK IBD Genetics Consortium Ulcerative Colitis Genome-Wide Association Study | Version 1: passed embargo
| VDAS | 1028 | Case-Control | Links | HumanHap300v2.0 HumanHap550v3.0
|
phs000130.v1.p1 NIDDK IBDGC Crohn's Disease Genome-Wide Association Study | Version 1: passed embargo
| VDAS | 1963 | Case-Control | Links | HumanHap300v1.1
|
phs000260.v4.p2 Foregut Microbiome in Development of Esophageal Adenocarcinoma | Versions 1-4: passed embargo
| VDAS | 110 | Case-Control | Links | 454 GS FLX Titanium HiSeq 2000
|
phs000262.v3.p2 The Role of the Gut Microbiota in Ulcerative Colitis | Versions 1-3: passed embargo
| VDAS | 50 | Longitudinal | Links | 454 GS FLX Titanium 454 GS FLX Titanium
|
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000697.v1.p1 Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome | Version 1: passed embargo
| VDAS | 39 | Clinical Trial, Interventional | Links | |
phs000695.v1.p1 A Phase I/II Trial of Sirolimus (Rapamune®) and Cyclosporine in Patients with Refractory Aplastic Anemia | Version 1: passed embargo
| VDAS | 17 | Clinical Trial, Interventional | Links | |
phs000594.v1.p1 A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia | Version 1: passed embargo
| VDAS | 9 | Interventional, Clinical Trial | Links | |
phs000575.v1.p1 PWS Natural History Protocol | Version 1: passed embargo
| VDAS | 200 | Case Set | | |
phs001318.v1.p1 Phase I/II Study of Revlimid/Azacitidine | Version 1: passed embargo
| VDAS | 50 | Case Set | Links | |
phs001328.v1.p1 Longitudinal Studies of Brain Structure and Function in MPS Disorders | Version 1: passed embargo
| VDAS | 93 | Longitudinal | Links | |
phs000103.v1.p1 GENEVA Study of Preterm Delivery (DNBC/Iowa) | Version 1: passed embargo
| VDAS | 4136 | Nested Case-Control, Mother-Child Pairs | Links | Human660W-Quad_v1_A
|
phs000455.v1.p1 Dobyns DBD | Version 1: passed embargo
| VDAS | 10 | Cohort | Links | SeqCap EZ Exome Library v2.0 liquid-phase sequence capture kit Genome Analyzer II Burrows-Wheeler Aligner (BWA) The Genome Analysis Toolkit (GTAK)
|